Citation Formats
UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Tasci Et Al. , "UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples," CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.4, pp.474-483, 2021

Tasci, Y. Et Al. 2021. UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples. CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.4 , 474-483.

Tasci, Y., Findik, R. B., Pekcan, M. K., KAPLAN, O., & ÇELEBİER, M., (2021). UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples. CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.4, 474-483.

Tasci, Yasemin Et Al. "UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples," CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.4, 474-483, 2021

Tasci, Yasemin Et Al. "UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples." CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.4, pp.474-483, 2021

Tasci, Y. Et Al. (2021) . "UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples." CURRENT PHARMACEUTICAL ANALYSIS , vol.17, no.4, pp.474-483.

@article{article, author={Yasemin Tasci Et Al. }, title={UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples}, journal={CURRENT PHARMACEUTICAL ANALYSIS}, year=2021, pages={474-483} }